# Kayla Y. Kamdar, MD – FDA Inspection, Feb 25, 2019

Source: https://www.keypedia.com/records/fda_inspections/kayla-y-kamdar-md/54c47001-b495-47f6-9ea3-9694915ba3ae
Source feed: FDA_Inspections

> FDA inspection 1092477 of Kayla Y. Kamdar, MD, February 25, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1092477
- Company Name: Kayla Y. Kamdar, MD
- Inspection Date: 2019-02-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/anya-d-lockett-evans/afddc255-78ab-472c-9a69-f4cb9967f180)

Company: https://www.keypedia.com/companies/kayla-y-kamdar-md/7dfc6c07-a43f-4957-b28f-e924f7b7acf0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
